Category: Zimmer Holdings
Abiomed's former director of investor relations, Susan Vissers Lisa, jumps ship for Boston Scientific's IR vice president role.
Susan Vissers Lisa, the former director of investor relations at Abiomed (NSDQ:ABMD), was named vice president of IR at Boston Scientific (NYSE:BSX).
CEO Josh Kornberg tells MassDevice.com about cleaning house and how bad news for rival Stryker Corp. is helping to reinvigorate Skyline Medical.
When John Kornberg joined then-BioDrain Medical in 2011 as an investor, the company had spent the past decade developing its Streamway surgical waste management device and getting clearance to commercialize it in the U.S. But, Kornberg told MassDevice.com recently, it was quickly apparent that BioDrain was stalled, unable to leverage its 510(k) clearance from the FDA into significant U.S. sales.
Orthopedics makers Zimmer and OrthoSensor join forces to market the Verasense system, a sensor-assisted surgical aid, alongside Zimmer's NexGen knee surgery platform.
Orthopedics giant Zimmer (NYSE:ZMH) and OrthoSensor signed a co-marketing agreement pairing Zimmer's NexGen knee systems with OrthoSensor's Verasense technology.
Zimmer Holdings narrows its earnings guidance after reporting lower profits during the 3rd quarter, sending share prices down today on Wall Street.
Zimmer (NYSE:ZMH) shares are down this morning after the orthopedic medical device company reported lower 3rd-quarter profits and narrowed its earnings guidance for the rest of the year.
Orthopedics giant Zimmer gets a new trial after a jury awards $27.6 million to a patient who claimed she re-injured her knee while making a promotional video.
The medical device industry's financial growth has been cut dramatically following the Great Recession, even as sales volume has returned to pre-crisis levels. Is there an end in sight?
The medical device industry has "lost" about $131 billion in revenues since the financial collapse of 2008, according to analysts at Ernst & Young.
The findings, taken from the audit firm's annual "Pulse of the Industry" report, paint a glum picture for the medtech industry, once considered to be "recession proof."
Zimmer Holdings inks a deal to distribute the lateral locking cage made by Frontier Medical Devices for spinal fusion surgeries.
Zimmer (NYSE:ZMH) said it inked an exclusive, long-term deal to distribute the lateral locking cage device made by Frontier Medical Devices for spinal fusion procedures.
The deal brings Zimmer into the lateral access market, Zimmer Spine president Steve Healy said in prepared remarks.